New accredited tests: Sterility and Bioburden testing
Renolab has expanded its ACCREDIA scope of accreditation with two new tests for the medical device sector: the Test of Sterility according to ISO 11737-2:2019 and Bioburden determination according to ISO 11737-1:2018/A1:2021.
These new tests complement the already accredited in vitro XTT cytotoxicity and skin irritation tests using reconstructed human epidermis, further strengthening the laboratory’s expertise in microbiological testing and cellular biocompatibility testing for medical devices.
Test of Sterility – ISO 11737-2:2019
The Test of Sterility is accredited for medical devices according to ISO 11737-2:2019.
The test is performed using a culture-based method and is applied within activities related to the definition, validation and maintenance of sterilization processes for medical devices.
Bioburden – ISO 11737-1:2018/A1:2021
Bioburden testing determines the population of microorganisms present on a sample, including:
- aerobic bacteria;
- anaerobic bacteria;
- yeasts;
- moulds.
The test is accredited for medical devices and raw materials for medical devices according to ISO 11737-1:2018/A1:2021.
Bioburden determination provides information on the microbiological contamination of a product and is particularly relevant for the management and control of processes preceding sterilization.
A broader range of accredited testing for the medical device sector
The two new tests complement Renolab’s existing accredited in vitro biocompatibility tests:
- In vitro cytotoxicity – XTT test, according to ISO 10993-12:2021/Amd1:2025 and ISO 10993-5:2009 – Annex D only;
- Skin irritation test using Reconstructed Human Epidermis (RhE), according to ISO 10993-12:2021/Amd1:2025 and ISO 10993-23:2021/Amd1:2025 – paragraph 6 only.
This extension of the scope of accreditation strengthens Renolab’s capabilities in the medical device sector by complementing its in vitro biocompatibility testing expertise with accredited microbiological tests.
Renolab is accredited by ACCREDIA under accreditation No. 02341 Testing, in accordance with UNI CEI EN ISO/IEC 17025:2018.
Renolab also operates according to the principles of Good Laboratory Practice (GLP) within the Italian national compliance system coordinated by the Ministry of Health, helping ensure the quality, integrity and traceability of the data generated.
For further information about the new accredited tests or to discuss specific testing requirements with our technical team: